Literature DB >> 19067236

The 4154delA mutation carriers in the BRCA1 gene share a common ancestry.

Silvija Ozolina1, Olga Sinicka, Eriks Jankevics, Inna Inashkina, Jan Lubinski, Bohdan Gorski, Jacek Gronwald, Tatyana Nasedkina, Olga Fedorova, Ludmila Lyubchenko, Laima Tihomirova.   

Abstract

Uncertainty exists whether the 4154delA mutation of the BRCA1 gene detected in unrelated individuals from Latvia, Poland and Russia is a founder mutation with a common ancestral origin. To trace back this problem we analysed the mutation-associated haplotype of the BRCA1 intragenic SNPs as well as intragenic and nearby STR markers in mutation carriers from the aforementioned populations. The mutation-associated SNP alleles were found to be "T-A-A-A-A-G" for six intragenic SNPs of the BRCA1 gene (IVS8-58delT, 3232A/G, 3667A/G, IVS16-68A/G, IVS16-92A/G, IVS18+66G/A, respectively). The alleles 195, 154, 210 and 181 were found to be associated with the 4154delA mutation for STR markers D17S1325, D17S855, D17S1328 and D17S1320, correspondingly. Further analysis of markers in the 4154delA mutation carriers from all three populations allows us to assert that all analysed mutation carriers share a common ancestry.

Entities:  

Mesh:

Year:  2008        PMID: 19067236     DOI: 10.1007/s10689-008-9224-6

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  8 in total

Review 1.  BRCA1 phosphorylation: biological consequences.

Authors:  Toru Ouchi
Journal:  Cancer Biol Ther       Date:  2006-05-30       Impact factor: 4.742

2.  Frequently occurring germ-line mutations of the BRCA1 gene in ovarian cancer families from Russia.

Authors:  S A Gayther; P Harrington; P Russell; G Kharkevich; R F Garkavtseva; B A Ponder
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

3.  High frequency of BRCA1 5382insC mutation in Russian breast cancer patients.

Authors:  Anna P Sokolenko; Natalia V Mitiushkina; Konstantin G Buslov; Elena M Bit-Sava; Aglaya G Iyevleva; Elena V Chekmariova; Ekatherina Sh Kuligina; Yulia M Ulibina; Maxim E Rozanov; Evgeny N Suspitsin; Dmitry E Matsko; Oleg L Chagunava; Dmitry Yu Trofimov; Peter Devilee; Cees Cornelisse; Alexandr V Togo; Vladimir F Semiglazov; Evgeny N Imyanitov
Journal:  Eur J Cancer       Date:  2006-06-05       Impact factor: 9.162

4.  High prevalence of two BRCA1 mutations, 4154delA and 5382insC, in Latvia.

Authors:  Laima Tikhomirova; Olga Sinicka; Dagnija Smite; Janis Eglitis; Shirley V Hodgson; Aivars Stengrevics
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

5.  Strong founder effects in BRCA1 mutation carrier breast cancer patients from Latvia. Mutation in brief no. 258. Online.

Authors:  B Csokay; L Tihomirova; A Stengrevics; O Sinicka; E Olah
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

6.  Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer.

Authors:  B Górski; T Byrski; T Huzarski; A Jakubowska; J Menkiszak; J Gronwald; A Pluzańska; M Bebenek; L Fischer-Maliszewska; E Grzybowska; S A Narod; J Lubiński
Journal:  Am J Hum Genet       Date:  2000-04-28       Impact factor: 11.025

7.  High incidence of 4153delA BRCA1 gene mutations in Lithuanian breast- and breast-ovarian cancer families.

Authors:  Jacek Gronwald; Pavel Elsakov; Bohdan Górski; Jan Lubiński
Journal:  Breast Cancer Res Treat       Date:  2005-11       Impact factor: 4.872

Review 8.  Functions of BRCA1 and BRCA2 in the biological response to DNA damage.

Authors:  A R Venkitaraman
Journal:  J Cell Sci       Date:  2001-10       Impact factor: 5.285

  8 in total
  2 in total

1.  Identification of the most common BRCA alterations through analysis of germline mutation databases: Is droplet digital PCR an additional strategy for the assessment of such alterations in breast and ovarian cancer families?

Authors:  Alessandro Lavoro; Aurora Scalisi; Saverio Candido; Guido Nicola Zanghì; Roberta Rizzo; Giuseppe Gattuso; Giuseppe Caruso; Massimo Libra; Luca Falzone
Journal:  Int J Oncol       Date:  2022-04-06       Impact factor: 5.650

2.  Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control.

Authors:  Ramūnas Janavičius
Journal:  EPMA J       Date:  2010-06-27       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.